Gut feelings about diabetes and GLP-1 receptor agonists: lessons to be learnt from studies in functional gastrointestinal disorders

Diabetes Obes Metab. 2017 Mar;19(3):309-312. doi: 10.1111/dom.12822. Epub 2016 Dec 8.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Autonomic Nervous System Diseases / drug therapy
  • Autonomic Nervous System Diseases / epidemiology
  • Autonomic Nervous System Diseases / etiology
  • Case-Control Studies
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / epidemiology*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetic Neuropathies / drug therapy
  • Diabetic Neuropathies / epidemiology
  • Emotions
  • Female
  • Gastric Emptying / drug effects
  • Gastrointestinal Diseases / drug therapy
  • Gastrointestinal Diseases / epidemiology*
  • Gastrointestinal Diseases / etiology
  • Gastrointestinal Motility / drug effects
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Prevalence

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents